OPHTHALMISCHE FORMULIERUNGEN
European patent · EP3827814 · In force
Register entry
- Publication number
- EP3827814
- Application number
- EP20209808
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Nov 25, 2020
- Published
- Jun 2, 2021
- Granted
- Dec 17, 2025
- Protection ends at the latest
- Nov 24, 2040
- Next annual fee due
- Nov 30, 2026
- IPC classes
- A61K 9/14 (2006.01)A61K 47/26 (2006.01)A61K 47/38 (2006.01)A61K 9/00 (2006.01)A61K 9/08 (2006.01)
- Priority
- IT 201900022029 25.11.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 28, 2026
Change
Published in Swissreg on 28.10.2026
- Dec 23, 2025
Agent entered
- Representative
- VALIPAT, c/o BOVARD LTD, Optingenstrasse 16, 3013 Bern
Published in Swissreg on 23.12.2025
- Dec 17, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 17.12.2025
Parties
Holder
Dompé farmaceutici S.p.A.
20122 Milano, IT
Agent
VALIPAT c/o BOVARD LTD
3013 Bern
Inventor
MANTELLI, Flavio
67100 L'Aquila, IT
GENTILE, Marco Maria
67100 L'Aquila, IT
DRAGANI, Maria Concetta
67100 L'Aquila, IT
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.